Observational Study of the Long-Term Efficacy of Ibogaine-Assisted Therapy (New Zealand)
This study is taking place at an independent ibogaine clinic in New Zealand. Its purpose is to examine the safety and long-term effectiveness of ibogaine treatment for opioid addiction severity and quality of life in 20 to 30 patients. This is an observational study (meaning that researchers do not administer the drug in the study but only survey people who have already been treated).
Presentation: Ibogaine Treatment in Aotearoa/New Zealand: Developing a Unique Model of Practice (PDF) by Geoff Noller, Ph.D.
The study was approved by the Ethics Committee on February 22, 2012.
This study has all necessary approvals and is now enrolling subjects.
MAPS has contributed $15,000 to this study, which was made possible by a generous $25,000 grant for ibogaine research from Matt and Kristi Bowden of Stargate International. This study will complement our ongoing ibogaine research program in Mexico, to which the remaining $10,000 of the Bowdens’ donation will be allocated.
Donations are needed to support research into ibogaine as a treatment for substance abuse and dependence. MAPS will allocate 100% of any donation specifically restricted to this work upon request.